As India's only legally approved GLP-1 provider, it ensures safe access to Semaglutide and Liraglutide under expert medical supervision
Methods: AEs data were extracted from the FDA Adverse Event Reporting System database for each GLP-1 RA from the time of its launch until the second quarter of 2023
Both direct and indirect modes of action are possible, including better blood glucose regulation, weight loss, and cardioprotective and renoprotective effects
Why does activating the glucagon receptor not cause dangerous blood sugar increases
If symptoms persist or worsen, prompt scheduling of a telehealth visit with Doctronic.ai can provide timely guidance and support
Document the name of the representative, the date, time, and reference number for the call